{"id":99944,"date":"2026-11-06T06:08:28","date_gmt":"2026-11-06T05:08:28","guid":{"rendered":"https:\/\/lasentinelle.dz\/?p=99944"},"modified":"2026-11-06T06:08:31","modified_gmt":"2026-11-06T05:08:31","slug":"industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques","status":"publish","type":"post","link":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/","title":{"rendered":"Industrie pharmaceutique\u00a0: Novartis lorgne le march\u00e9 des th\u00e9rapies g\u00e9niques"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Alger cherche des partenaires industriels pour son futur institut de th\u00e9rapie g\u00e9nique, et Novartis se met sur les rangs. Le groupe suisse, sp\u00e9cialis\u00e9 dans le d\u00e9veloppement et la production de m\u00e9dicaments innovants, a d\u00e9p\u00each\u00e9 une d\u00e9l\u00e9gation dans la capitale. Elle a \u00e9t\u00e9 re\u00e7ue mardi par le ministre de l&rsquo;Industrie pharmaceutique, Ouacim Kouidri, en pr\u00e9sence de l&rsquo;ambassadrice de la Conf\u00e9d\u00e9ration suisse en Alg\u00e9rie, Marion Weichelt Krupski. Les discussions ont port\u00e9 sur le renforcement des partenariats industriels, l&rsquo;\u00e9change d&rsquo;expertises et le d\u00e9veloppement des capacit\u00e9s nationales, indique un communiqu\u00e9 du minist\u00e8re rendu public ce mercredi. La rencontre a d&rsquo;abord permis de passer en revue les activit\u00e9s de Novartis en Alg\u00e9rie comme \u00e0 l&rsquo;international. Le minist\u00e8re retient \u00ab son expertise et ses capacit\u00e9s dans le d\u00e9veloppement et la production de m\u00e9dicaments innovants \u00bb, auxquelles s&rsquo;ajoutent des travaux de recherche scientifique et technologique, \u00ab notamment dans les th\u00e9rapies g\u00e9niques et les biotechnologies avanc\u00e9es \u00bb. Un profil qui colle au chantier que les autorit\u00e9s entendent faire avancer.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pour les pouvoirs publics, l&rsquo;enjeu est autant industriel que sanitaire. Ouacim Kouidri a r\u00e9affirm\u00e9 que son secteur se tient pr\u00eat \u00e0 accompagner les op\u00e9rateurs \u00e9conomiques d\u00e9sireux de d\u00e9velopper leurs activit\u00e9s et d&rsquo;investir en Alg\u00e9rie. Il en attend un renforcement des partenariats industriels, un transfert d&rsquo;expertises et de technologies modernes, ainsi qu&rsquo;une mont\u00e9e en puissance des capacit\u00e9s locales de production et de prise en charge.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Le ministre a surtout mis en avant \u00ab l&rsquo;importance strat\u00e9gique \u00bb de l&rsquo;Institut alg\u00e9rien de th\u00e9rapie cellulaire et g\u00e9nique, dont la r\u00e9alisation est supervis\u00e9e par le groupe public Saidal, en coop\u00e9ration avec des firmes \u00e9trang\u00e8res de renom. Il y voit un \u00ab projet national ambitieux visant \u00e0 assurer des technologies th\u00e9rapeutiques avanc\u00e9es en Alg\u00e9rie et \u00e0 consolider les capacit\u00e9s de prise en charge des patients, \u00e0 la pointe des derni\u00e8res innovations scientifiques et m\u00e9dicales \u00bb. Les th\u00e9rapies g\u00e9niques, qui ouvrent des perspectives prometteuses face \u00e0 de nombreuses pathologies incurables, doivent selon lui apporter une valeur ajout\u00e9e aux soins et aux services de l&rsquo;Institut. Elles permettront aussi d&rsquo;\u00e9largir l&rsquo;acc\u00e8s aux technologies th\u00e9rapeutiques modernes, ce qui consolidera la souverainet\u00e9 sanitaire du pays et \u00e9l\u00e8vera le niveau des prestations offertes aux citoyens. L&rsquo;argument vaut aussi sur le plan \u00e9conomique, puisqu&rsquo;il s&rsquo;agit de produire et de ma\u00eetriser localement des traitements aujourd&rsquo;hui hors de port\u00e9e du tissu industriel national. L&rsquo;ambassadrice suisse s&rsquo;est de son c\u00f4t\u00e9 f\u00e9licit\u00e9e de la qualit\u00e9 des relations bilat\u00e9rales, singuli\u00e8rement dans l&rsquo;industrie pharmaceutique. Elle a exprim\u00e9 son int\u00e9r\u00eat pour un renforcement de la coop\u00e9ration et pour l&rsquo;\u00e9largissement de ses perspectives, \u00e0 travers des partenariats dans les m\u00e9dicaments innovants, les technologies th\u00e9rapeutiques avanc\u00e9es et le transfert de technologie. Lyna Larbi<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Alger cherche des partenaires industriels pour son futur institut de th\u00e9rapie g\u00e9nique, et Novartis se met sur les rangs. Le<\/p>\n","protected":false},"author":6,"featured_media":99945,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"colormag_page_container_layout":"default_layout","colormag_page_sidebar_layout":"default_layout","om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"video_url":"","footnotes":"","_wpscppro_dont_share_socialmedia":false,"_wpscppro_custom_social_share_image":0,"_facebook_share_type":"default","_twitter_share_type":"default","_linkedin_share_type":"default","_pinterest_share_type":"default","_linkedin_share_type_page":"","_instagram_share_type":"default","_medium_share_type":"default","_threads_share_type":"default","_bluesky_share_type":"default","_mastodon_share_type":"default","_selected_social_profile":[],"_wpsp_enable_custom_social_template":false,"_wpsp_social_scheduling":{"enabled":false,"datetime":null,"platforms":[],"status":"template_only","dateOption":"","timeOption":"","customDays":"","customHours":"","customDate":"","customTime":"","schedulingType":""},"_wpsp_active_default_template":true},"categories":[29],"tags":[],"class_list":["post-99944","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-economie"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"Alger cherche des partenaires industriels pour son futur institut de th\u00e9rapie g\u00e9nique, et Novartis se met sur les rangs. Le groupe suisse, sp\u00e9cialis\u00e9 dans le d\u00e9veloppement et la production de m\u00e9dicaments innovants, a d\u00e9p\u00each\u00e9 une d\u00e9l\u00e9gation dans la capitale. Elle a \u00e9t\u00e9 re\u00e7ue mardi par le ministre de l&#039;Industrie pharmaceutique, Ouacim Kouidri, en pr\u00e9sence de\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"fr_FR\" \/>\n\t\t<meta property=\"og:site_name\" content=\"La Sentinelle - Quotidien national d&#039;information\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Industrie pharmaceutique : Novartis lorgne le march\u00e9 des th\u00e9rapies g\u00e9niques - La Sentinelle\" \/>\n\t\t<meta property=\"og:description\" content=\"Alger cherche des partenaires industriels pour son futur institut de th\u00e9rapie g\u00e9nique, et Novartis se met sur les rangs. Le groupe suisse, sp\u00e9cialis\u00e9 dans le d\u00e9veloppement et la production de m\u00e9dicaments innovants, a d\u00e9p\u00each\u00e9 une d\u00e9l\u00e9gation dans la capitale. Elle a \u00e9t\u00e9 re\u00e7ue mardi par le ministre de l&#039;Industrie pharmaceutique, Ouacim Kouidri, en pr\u00e9sence de\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/lasentinelle.dz\/wp-content\/uploads\/2021\/09\/cropped-la-sentinelle-earth-golden-anima-5.gif\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/lasentinelle.dz\/wp-content\/uploads\/2021\/09\/cropped-la-sentinelle-earth-golden-anima-5.gif\" \/>\n\t\t<meta property=\"og:image:width\" content=\"450\" \/>\n\t\t<meta property=\"og:image:height\" content=\"213\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-11-06T05:08:28+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-11-06T05:08:31+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/azzedine.lasentinelle.1\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Industrie pharmaceutique : Novartis lorgne le march\u00e9 des th\u00e9rapies g\u00e9niques - La Sentinelle\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Alger cherche des partenaires industriels pour son futur institut de th\u00e9rapie g\u00e9nique, et Novartis se met sur les rangs. Le groupe suisse, sp\u00e9cialis\u00e9 dans le d\u00e9veloppement et la production de m\u00e9dicaments innovants, a d\u00e9p\u00each\u00e9 une d\u00e9l\u00e9gation dans la capitale. Elle a \u00e9t\u00e9 re\u00e7ue mardi par le ministre de l&#039;Industrie pharmaceutique, Ouacim Kouidri, en pr\u00e9sence de\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/lasentinelle.dz\/wp-content\/uploads\/2021\/09\/cropped-la-sentinelle-earth-golden-anima-5.gif\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/#blogposting\",\"name\":\"Industrie pharmaceutique : Novartis lorgne le march\\u00e9 des th\\u00e9rapies g\\u00e9niques - La Sentinelle\",\"headline\":\"Industrie pharmaceutique\\u00a0: Novartis lorgne le march\\u00e9 des th\\u00e9rapies g\\u00e9niques\",\"author\":{\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/author\\\/admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/lasentinelle.dz\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/novartis.jpeg\",\"width\":650,\"height\":325},\"datePublished\":\"2026-11-06T06:08:28+01:00\",\"dateModified\":\"2026-11-06T06:08:31+01:00\",\"inLanguage\":\"fr-FR\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/#webpage\"},\"articleSection\":\"\\u00c9conomie\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/lasentinelle.dz\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/category\\\/economie\\\/#listItem\",\"name\":\"\\u00c9conomie\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/category\\\/economie\\\/#listItem\",\"position\":2,\"name\":\"\\u00c9conomie\",\"item\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/category\\\/economie\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/#listItem\",\"name\":\"Industrie pharmaceutique\\u00a0: Novartis lorgne le march\\u00e9 des th\\u00e9rapies g\\u00e9niques\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/#listItem\",\"position\":3,\"name\":\"Industrie pharmaceutique\\u00a0: Novartis lorgne le march\\u00e9 des th\\u00e9rapies g\\u00e9niques\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/category\\\/economie\\\/#listItem\",\"name\":\"\\u00c9conomie\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/#organization\",\"name\":\"La Sentinelle La Sentinelle\",\"description\":\"Quotidien national d'information\",\"url\":\"https:\\\/\\\/lasentinelle.dz\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/lasentinelle.dz\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/cropped-la-sentinelle-earth-golden-anima-5.gif\",\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/#organizationLogo\",\"width\":450,\"height\":213},\"image\":{\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/azzedine.lasentinelle.1\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/lasentinelle.dz\\\/author\\\/admin\\\/\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4c81fed838786e9b53f540bf46533e750f5d292099ae3b66cfc6fb1982e29df7?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/#webpage\",\"url\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/\",\"name\":\"Industrie pharmaceutique : Novartis lorgne le march\\u00e9 des th\\u00e9rapies g\\u00e9niques - La Sentinelle\",\"description\":\"Alger cherche des partenaires industriels pour son futur institut de th\\u00e9rapie g\\u00e9nique, et Novartis se met sur les rangs. Le groupe suisse, sp\\u00e9cialis\\u00e9 dans le d\\u00e9veloppement et la production de m\\u00e9dicaments innovants, a d\\u00e9p\\u00each\\u00e9 une d\\u00e9l\\u00e9gation dans la capitale. Elle a \\u00e9t\\u00e9 re\\u00e7ue mardi par le ministre de l'Industrie pharmaceutique, Ouacim Kouidri, en pr\\u00e9sence de\",\"inLanguage\":\"fr-FR\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/author\\\/admin\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/lasentinelle.dz\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/novartis.jpeg\",\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/#mainImage\",\"width\":650,\"height\":325},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/#mainImage\"},\"datePublished\":\"2026-11-06T06:08:28+01:00\",\"dateModified\":\"2026-11-06T06:08:31+01:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/#website\",\"url\":\"https:\\\/\\\/lasentinelle.dz\\\/\",\"name\":\"La Sentinelle\",\"description\":\"Quotidien national d'information\",\"inLanguage\":\"fr-FR\",\"publisher\":{\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Industrie pharmaceutique : Novartis lorgne le march\u00e9 des th\u00e9rapies g\u00e9niques - La Sentinelle","description":"Alger cherche des partenaires industriels pour son futur institut de th\u00e9rapie g\u00e9nique, et Novartis se met sur les rangs. Le groupe suisse, sp\u00e9cialis\u00e9 dans le d\u00e9veloppement et la production de m\u00e9dicaments innovants, a d\u00e9p\u00each\u00e9 une d\u00e9l\u00e9gation dans la capitale. Elle a \u00e9t\u00e9 re\u00e7ue mardi par le ministre de l'Industrie pharmaceutique, Ouacim Kouidri, en pr\u00e9sence de","canonical_url":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/#blogposting","name":"Industrie pharmaceutique : Novartis lorgne le march\u00e9 des th\u00e9rapies g\u00e9niques - La Sentinelle","headline":"Industrie pharmaceutique\u00a0: Novartis lorgne le march\u00e9 des th\u00e9rapies g\u00e9niques","author":{"@id":"https:\/\/lasentinelle.dz\/author\/admin\/#author"},"publisher":{"@id":"https:\/\/lasentinelle.dz\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/lasentinelle.dz\/wp-content\/uploads\/2026\/11\/novartis.jpeg","width":650,"height":325},"datePublished":"2026-11-06T06:08:28+01:00","dateModified":"2026-11-06T06:08:31+01:00","inLanguage":"fr-FR","mainEntityOfPage":{"@id":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/#webpage"},"isPartOf":{"@id":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/#webpage"},"articleSection":"\u00c9conomie"},{"@type":"BreadcrumbList","@id":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/lasentinelle.dz\/#listItem","position":1,"name":"Home","item":"https:\/\/lasentinelle.dz\/","nextItem":{"@type":"ListItem","@id":"https:\/\/lasentinelle.dz\/index.php\/category\/economie\/#listItem","name":"\u00c9conomie"}},{"@type":"ListItem","@id":"https:\/\/lasentinelle.dz\/index.php\/category\/economie\/#listItem","position":2,"name":"\u00c9conomie","item":"https:\/\/lasentinelle.dz\/index.php\/category\/economie\/","nextItem":{"@type":"ListItem","@id":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/#listItem","name":"Industrie pharmaceutique\u00a0: Novartis lorgne le march\u00e9 des th\u00e9rapies g\u00e9niques"},"previousItem":{"@type":"ListItem","@id":"https:\/\/lasentinelle.dz\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/#listItem","position":3,"name":"Industrie pharmaceutique\u00a0: Novartis lorgne le march\u00e9 des th\u00e9rapies g\u00e9niques","previousItem":{"@type":"ListItem","@id":"https:\/\/lasentinelle.dz\/index.php\/category\/economie\/#listItem","name":"\u00c9conomie"}}]},{"@type":"Organization","@id":"https:\/\/lasentinelle.dz\/#organization","name":"La Sentinelle La Sentinelle","description":"Quotidien national d'information","url":"https:\/\/lasentinelle.dz\/","logo":{"@type":"ImageObject","url":"https:\/\/lasentinelle.dz\/wp-content\/uploads\/2021\/09\/cropped-la-sentinelle-earth-golden-anima-5.gif","@id":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/#organizationLogo","width":450,"height":213},"image":{"@id":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/azzedine.lasentinelle.1"]},{"@type":"Person","@id":"https:\/\/lasentinelle.dz\/author\/admin\/#author","url":"https:\/\/lasentinelle.dz\/author\/admin\/","name":"admin","image":{"@type":"ImageObject","@id":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/4c81fed838786e9b53f540bf46533e750f5d292099ae3b66cfc6fb1982e29df7?s=96&d=mm&r=g","width":96,"height":96,"caption":"admin"}},{"@type":"WebPage","@id":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/#webpage","url":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/","name":"Industrie pharmaceutique : Novartis lorgne le march\u00e9 des th\u00e9rapies g\u00e9niques - La Sentinelle","description":"Alger cherche des partenaires industriels pour son futur institut de th\u00e9rapie g\u00e9nique, et Novartis se met sur les rangs. Le groupe suisse, sp\u00e9cialis\u00e9 dans le d\u00e9veloppement et la production de m\u00e9dicaments innovants, a d\u00e9p\u00each\u00e9 une d\u00e9l\u00e9gation dans la capitale. Elle a \u00e9t\u00e9 re\u00e7ue mardi par le ministre de l'Industrie pharmaceutique, Ouacim Kouidri, en pr\u00e9sence de","inLanguage":"fr-FR","isPartOf":{"@id":"https:\/\/lasentinelle.dz\/#website"},"breadcrumb":{"@id":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/#breadcrumblist"},"author":{"@id":"https:\/\/lasentinelle.dz\/author\/admin\/#author"},"creator":{"@id":"https:\/\/lasentinelle.dz\/author\/admin\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/lasentinelle.dz\/wp-content\/uploads\/2026\/11\/novartis.jpeg","@id":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/#mainImage","width":650,"height":325},"primaryImageOfPage":{"@id":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/#mainImage"},"datePublished":"2026-11-06T06:08:28+01:00","dateModified":"2026-11-06T06:08:31+01:00"},{"@type":"WebSite","@id":"https:\/\/lasentinelle.dz\/#website","url":"https:\/\/lasentinelle.dz\/","name":"La Sentinelle","description":"Quotidien national d'information","inLanguage":"fr-FR","publisher":{"@id":"https:\/\/lasentinelle.dz\/#organization"}}]},"og:locale":"fr_FR","og:site_name":"La Sentinelle - Quotidien national d'information","og:type":"article","og:title":"Industrie pharmaceutique : Novartis lorgne le march\u00e9 des th\u00e9rapies g\u00e9niques - La Sentinelle","og:description":"Alger cherche des partenaires industriels pour son futur institut de th\u00e9rapie g\u00e9nique, et Novartis se met sur les rangs. Le groupe suisse, sp\u00e9cialis\u00e9 dans le d\u00e9veloppement et la production de m\u00e9dicaments innovants, a d\u00e9p\u00each\u00e9 une d\u00e9l\u00e9gation dans la capitale. Elle a \u00e9t\u00e9 re\u00e7ue mardi par le ministre de l'Industrie pharmaceutique, Ouacim Kouidri, en pr\u00e9sence de","og:url":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/","og:image":"https:\/\/lasentinelle.dz\/wp-content\/uploads\/2021\/09\/cropped-la-sentinelle-earth-golden-anima-5.gif","og:image:secure_url":"https:\/\/lasentinelle.dz\/wp-content\/uploads\/2021\/09\/cropped-la-sentinelle-earth-golden-anima-5.gif","og:image:width":450,"og:image:height":213,"article:published_time":"2026-11-06T05:08:28+00:00","article:modified_time":"2026-11-06T05:08:31+00:00","article:publisher":"https:\/\/www.facebook.com\/azzedine.lasentinelle.1","twitter:card":"summary_large_image","twitter:title":"Industrie pharmaceutique : Novartis lorgne le march\u00e9 des th\u00e9rapies g\u00e9niques - La Sentinelle","twitter:description":"Alger cherche des partenaires industriels pour son futur institut de th\u00e9rapie g\u00e9nique, et Novartis se met sur les rangs. Le groupe suisse, sp\u00e9cialis\u00e9 dans le d\u00e9veloppement et la production de m\u00e9dicaments innovants, a d\u00e9p\u00each\u00e9 une d\u00e9l\u00e9gation dans la capitale. Elle a \u00e9t\u00e9 re\u00e7ue mardi par le ministre de l'Industrie pharmaceutique, Ouacim Kouidri, en pr\u00e9sence de","twitter:image":"https:\/\/lasentinelle.dz\/wp-content\/uploads\/2021\/09\/cropped-la-sentinelle-earth-golden-anima-5.gif"},"aioseo_meta_data":{"post_id":"99944","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":{"faqs":[],"keyPoints":[],"schemas":[],"titles":[],"descriptions":[],"socialPosts":{"email":{"subject":"","preview":"","content":""},"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2026-11-06 05:08:31","updated":"2026-11-06 05:48:02","focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/lasentinelle.dz\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/lasentinelle.dz\/index.php\/category\/economie\/\" title=\"\u00c9conomie\">\u00c9conomie<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tIndustrie pharmaceutique : Novartis lorgne le march\u00e9 des th\u00e9rapies g\u00e9niques\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/lasentinelle.dz\/"},{"label":"\u00c9conomie","link":"https:\/\/lasentinelle.dz\/index.php\/category\/economie\/"},{"label":"Industrie pharmaceutique\u00a0: Novartis lorgne le march\u00e9 des th\u00e9rapies g\u00e9niques","link":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/"}],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Industrie pharmaceutique\u00a0: Novartis lorgne le march\u00e9 des th\u00e9rapies g\u00e9niques - La Sentinelle<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Industrie pharmaceutique\u00a0: Novartis lorgne le march\u00e9 des th\u00e9rapies g\u00e9niques - La Sentinelle\" \/>\n<meta property=\"og:description\" content=\"Alger cherche des partenaires industriels pour son futur institut de th\u00e9rapie g\u00e9nique, et Novartis se met sur les rangs. Le\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/\" \/>\n<meta property=\"og:site_name\" content=\"La Sentinelle\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/La-Sentinelle-104059864394773\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-06T05:08:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-06T05:08:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/lasentinelle.dz\/wp-content\/uploads\/2026\/11\/novartis.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"650\" \/>\n\t<meta property=\"og:image:height\" content=\"325\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/#\\\/schema\\\/person\\\/729ee0024f24e0b8c5ec17232f8e8b41\"},\"headline\":\"Industrie pharmaceutique\u00a0: Novartis lorgne le march\u00e9 des th\u00e9rapies g\u00e9niques\",\"datePublished\":\"2026-11-06T05:08:28+00:00\",\"dateModified\":\"2026-11-06T05:08:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/\"},\"wordCount\":521,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/lasentinelle.dz\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/novartis.jpeg\",\"articleSection\":[\"\u00c9conomie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/\",\"url\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/\",\"name\":\"Industrie pharmaceutique\u00a0: Novartis lorgne le march\u00e9 des th\u00e9rapies g\u00e9niques - La Sentinelle\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/lasentinelle.dz\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/novartis.jpeg\",\"datePublished\":\"2026-11-06T05:08:28+00:00\",\"dateModified\":\"2026-11-06T05:08:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/#primaryimage\",\"url\":\"https:\\\/\\\/lasentinelle.dz\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/novartis.jpeg\",\"contentUrl\":\"https:\\\/\\\/lasentinelle.dz\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/novartis.jpeg\",\"width\":650,\"height\":325},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/index.php\\\/2026\\\/11\\\/06\\\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/lasentinelle.dz\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Industrie pharmaceutique\u00a0: Novartis lorgne le march\u00e9 des th\u00e9rapies g\u00e9niques\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/#website\",\"url\":\"https:\\\/\\\/lasentinelle.dz\\\/\",\"name\":\"La Sentinelle\",\"description\":\"Quotidien national d&#039;information\",\"publisher\":{\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/lasentinelle.dz\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/#organization\",\"name\":\"Quotidien La Sentinelle\",\"url\":\"https:\\\/\\\/lasentinelle.dz\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/lasentinelle.dz\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/logo-sentinelleSLOGAN-1.png\",\"contentUrl\":\"https:\\\/\\\/lasentinelle.dz\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/logo-sentinelleSLOGAN-1.png\",\"width\":615,\"height\":142,\"caption\":\"Quotidien La Sentinelle\"},\"image\":{\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/La-Sentinelle-104059864394773\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/lasentinelle.dz\\\/#\\\/schema\\\/person\\\/729ee0024f24e0b8c5ec17232f8e8b41\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4c81fed838786e9b53f540bf46533e750f5d292099ae3b66cfc6fb1982e29df7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4c81fed838786e9b53f540bf46533e750f5d292099ae3b66cfc6fb1982e29df7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4c81fed838786e9b53f540bf46533e750f5d292099ae3b66cfc6fb1982e29df7?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"description\":\"admin\",\"url\":\"https:\\\/\\\/lasentinelle.dz\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Industrie pharmaceutique\u00a0: Novartis lorgne le march\u00e9 des th\u00e9rapies g\u00e9niques - La Sentinelle","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/","og_locale":"fr_FR","og_type":"article","og_title":"Industrie pharmaceutique\u00a0: Novartis lorgne le march\u00e9 des th\u00e9rapies g\u00e9niques - La Sentinelle","og_description":"Alger cherche des partenaires industriels pour son futur institut de th\u00e9rapie g\u00e9nique, et Novartis se met sur les rangs. Le","og_url":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/","og_site_name":"La Sentinelle","article_publisher":"https:\/\/www.facebook.com\/La-Sentinelle-104059864394773","article_published_time":"2026-11-06T05:08:28+00:00","article_modified_time":"2026-11-06T05:08:31+00:00","og_image":[{"width":650,"height":325,"url":"https:\/\/lasentinelle.dz\/wp-content\/uploads\/2026\/11\/novartis.jpeg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"admin","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/#article","isPartOf":{"@id":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/"},"author":{"name":"admin","@id":"https:\/\/lasentinelle.dz\/#\/schema\/person\/729ee0024f24e0b8c5ec17232f8e8b41"},"headline":"Industrie pharmaceutique\u00a0: Novartis lorgne le march\u00e9 des th\u00e9rapies g\u00e9niques","datePublished":"2026-11-06T05:08:28+00:00","dateModified":"2026-11-06T05:08:31+00:00","mainEntityOfPage":{"@id":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/"},"wordCount":521,"commentCount":0,"publisher":{"@id":"https:\/\/lasentinelle.dz\/#organization"},"image":{"@id":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/#primaryimage"},"thumbnailUrl":"https:\/\/lasentinelle.dz\/wp-content\/uploads\/2026\/11\/novartis.jpeg","articleSection":["\u00c9conomie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/","url":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/","name":"Industrie pharmaceutique\u00a0: Novartis lorgne le march\u00e9 des th\u00e9rapies g\u00e9niques - La Sentinelle","isPartOf":{"@id":"https:\/\/lasentinelle.dz\/#website"},"primaryImageOfPage":{"@id":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/#primaryimage"},"image":{"@id":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/#primaryimage"},"thumbnailUrl":"https:\/\/lasentinelle.dz\/wp-content\/uploads\/2026\/11\/novartis.jpeg","datePublished":"2026-11-06T05:08:28+00:00","dateModified":"2026-11-06T05:08:31+00:00","breadcrumb":{"@id":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/#primaryimage","url":"https:\/\/lasentinelle.dz\/wp-content\/uploads\/2026\/11\/novartis.jpeg","contentUrl":"https:\/\/lasentinelle.dz\/wp-content\/uploads\/2026\/11\/novartis.jpeg","width":650,"height":325},{"@type":"BreadcrumbList","@id":"https:\/\/lasentinelle.dz\/index.php\/2026\/11\/06\/industrie-pharmaceutique-novartis-lorgne-le-marche-des-therapies-geniques\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/lasentinelle.dz\/"},{"@type":"ListItem","position":2,"name":"Industrie pharmaceutique\u00a0: Novartis lorgne le march\u00e9 des th\u00e9rapies g\u00e9niques"}]},{"@type":"WebSite","@id":"https:\/\/lasentinelle.dz\/#website","url":"https:\/\/lasentinelle.dz\/","name":"La Sentinelle","description":"Quotidien national d&#039;information","publisher":{"@id":"https:\/\/lasentinelle.dz\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lasentinelle.dz\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/lasentinelle.dz\/#organization","name":"Quotidien La Sentinelle","url":"https:\/\/lasentinelle.dz\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/lasentinelle.dz\/#\/schema\/logo\/image\/","url":"https:\/\/lasentinelle.dz\/wp-content\/uploads\/2021\/09\/logo-sentinelleSLOGAN-1.png","contentUrl":"https:\/\/lasentinelle.dz\/wp-content\/uploads\/2021\/09\/logo-sentinelleSLOGAN-1.png","width":615,"height":142,"caption":"Quotidien La Sentinelle"},"image":{"@id":"https:\/\/lasentinelle.dz\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/La-Sentinelle-104059864394773"]},{"@type":"Person","@id":"https:\/\/lasentinelle.dz\/#\/schema\/person\/729ee0024f24e0b8c5ec17232f8e8b41","name":"admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/4c81fed838786e9b53f540bf46533e750f5d292099ae3b66cfc6fb1982e29df7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4c81fed838786e9b53f540bf46533e750f5d292099ae3b66cfc6fb1982e29df7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4c81fed838786e9b53f540bf46533e750f5d292099ae3b66cfc6fb1982e29df7?s=96&d=mm&r=g","caption":"admin"},"description":"admin","url":"https:\/\/lasentinelle.dz\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/lasentinelle.dz\/index.php\/wp-json\/wp\/v2\/posts\/99944","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lasentinelle.dz\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lasentinelle.dz\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lasentinelle.dz\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/lasentinelle.dz\/index.php\/wp-json\/wp\/v2\/comments?post=99944"}],"version-history":[{"count":1,"href":"https:\/\/lasentinelle.dz\/index.php\/wp-json\/wp\/v2\/posts\/99944\/revisions"}],"predecessor-version":[{"id":99946,"href":"https:\/\/lasentinelle.dz\/index.php\/wp-json\/wp\/v2\/posts\/99944\/revisions\/99946"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lasentinelle.dz\/index.php\/wp-json\/wp\/v2\/media\/99945"}],"wp:attachment":[{"href":"https:\/\/lasentinelle.dz\/index.php\/wp-json\/wp\/v2\/media?parent=99944"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lasentinelle.dz\/index.php\/wp-json\/wp\/v2\/categories?post=99944"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lasentinelle.dz\/index.php\/wp-json\/wp\/v2\/tags?post=99944"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}